Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 7981–8000 of 17,529 recalls

November 2, 2018· Sandoz Inc

Recalled Item: Isosorbide Dinitrate Tablets

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 2, 2018· Sandoz Inc

Recalled Item: Isosorbide Dinitrate Tablets

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 2, 2018· Sandoz Inc

Recalled Item: Isosorbide Dinitrate Tablets

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 2, 2018· Sandoz Inc

Recalled Item: Isosorbide Dinitrate Tablets

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 1, 2018· Bound Tree Medical, LLC

Recalled Item: curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit

The Issue: Labeling: Incorrect or Missing Lot and/or Exp date:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 1, 2018· Bound Tree Medical, LLC

Recalled Item: Curaplex Epi Safe Kit

The Issue: Labeling: Incorrect or missing Lot and/or Exp Date:The

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 1, 2018· Sandoz, Inc

Recalled Item: Sandoz Losartan Potassium and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 31, 2018· Avella of Deer Valley, Inc. Store 38

Recalled Item: BEVACIZUMAB 2.5 MG/0.1ML

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· GE Healthcare Inc. Life Sciences

Recalled Item: Omnipaque (iohexol) Injection

The Issue: Defective Container: vial defect was identified that could

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Akorn, Inc.

Recalled Item: Clindamycin Phosphate Topical Solution USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 26, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam in 0.54 % Sodium Chloride Injection 1

The Issue: Labeling: Label Error on Declared Strength; the pre-printed

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund